发明公开
- 专利标题： CXCR3 RECEPTOR ANTAGONISTS
- 专利标题（中）： CXCR3受体拮抗剂
-
申请号： EP10715470.0申请日： 2010-04-26
-
公开(公告)号： EP2424840A1公开(公告)日： 2012-03-07
- 发明人: KOWALSKI, Jennifer A. , MARSHALL, Daniel Richard , PROKOPOWICZ, Anthony S. III , SCHLYER, Sabine , SIBLEY, Robert , SORCEK, Ronald John , WU, Di , WU, Frank , YOUNG, Erick Richard Roush
- 申请人： Boehringer Ingelheim International GmbH
- 申请人地址： Binger Strasse 173 55216 Ingelheim DE
- 专利权人： Boehringer Ingelheim International GmbH
- 当前专利权人： Boehringer Ingelheim International GmbH
- 当前专利权人地址： Binger Strasse 173 55216 Ingelheim DE
- 代理机构： Hammann, Heinz
- 优先权： US172873P 20090427; US319482P 20100331
- 国际公布： WO2010126811 20101104
- 主分类号： C07D209/48
- IPC分类号： C07D209/48 ; C07D213/26 ; C07D213/56 ; C07D213/65 ; C07D213/74 ; C07D217/00 ; C07D231/10 ; C07D233/90 ; C07D235/04 ; C07D239/34 ; C07D239/42 ; C07D277/30 ; C07D307/68 ; C07D317/68 ; C07D319/18
摘要：
The present invention relates to compounds of formula (I), and pharmaceutically acceptable salts thereof, wherein R
1 to R
5 , A, B, D and X are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.
1 to R
5 , A, B, D and X are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.
公开/授权文献
- EP2424840B1 CXCR3 RECEPTOR ANTAGONISTS 公开/授权日：2014-08-06
信息查询
